UPDATE: UBS Downgrades Northrop Grumman (NOC) to Sell; Large Risk to U.S. Budget
Get Alerts NOC Hot Sheet
Price: $474.57 --0%
Rating Summary:
13 Buy, 12 Hold, 2 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Rating Summary:
13 Buy, 12 Hold, 2 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Join SI Premium – FREE
(Updated - September 13, 2012 10:55 AM EDT)
UBS downgraded Northrop Grumman (NYSE: NOC) from Neutral to Sell. PT raised $1 to $64.
Analyst, David E. Strauss, said, "NOC has outperformed the market and defense from the bottom, all but eliminating its historical discount to the group. We are downgrading our rating given NOC’s outsized exposure to the declining US budget and potential sequestration. Our forward EPS estimates are well below consensus expectations."
FY13 EPS estimates lowered from $7.20 to $7.05.
For an analyst ratings summary and ratings history on Northrop Grumman click here. For more ratings news on Northrop Grumman click here.
Shares of Northrop Grumman closed at $67.93 yesterday.
UBS downgraded Northrop Grumman (NYSE: NOC) from Neutral to Sell. PT raised $1 to $64.
Analyst, David E. Strauss, said, "NOC has outperformed the market and defense from the bottom, all but eliminating its historical discount to the group. We are downgrading our rating given NOC’s outsized exposure to the declining US budget and potential sequestration. Our forward EPS estimates are well below consensus expectations."
FY13 EPS estimates lowered from $7.20 to $7.05.
For an analyst ratings summary and ratings history on Northrop Grumman click here. For more ratings news on Northrop Grumman click here.
Shares of Northrop Grumman closed at $67.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teledyne (TDY) PT Lowered to $455 at Needham
- Biogen (BIIB) PT Lowered to $300 at H.C. Wainwright
- Jefferies Downgrades Calix (CALX) to Hold
Create E-mail Alert Related Categories
Analyst EPS Change, Analyst EPS View, Analyst PT Change, DowngradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!